VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries

Regulatory Peptides

Volumn 110, Issue 3, 2003, Pages 179-188

  Dalsgaard, Tórur ^a   Hannibal, Jens ^b   Fahrenkrug, Jan ^b   Larsen, Christian Rifbjerg ^a   Ottesen, Bent ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Blood flow; Cardiovascular diseases; Hormones; Peptides

Indexed keywords

ESTRADIOL; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NORETHISTERONE ACETATE; PEPTIDE DERIVATIVE; PLACEBO; SEX HORMONE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ARTICLE; BRAIN ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY BLOOD VESSEL; DRUG EFFECT; FEMALE; IMMUNOHISTOCHEMISTRY; INNERVATION; MYOGRAPHY; NERVE FIBER; NEW ZEALAND; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOIMMUNOASSAY; RANDOMIZATION;

ANIMALS; CEREBRAL ARTERIES; CORONARY VESSELS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RABBITS; VASOACTIVE INTESTINAL PEPTIDE; VASODILATION;

ORYCTOLAGUS CUNICULUS;

EID: 0037469927     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00205-7     Document Type: Article

References (40)

1. Fahrenkrug J. Transmitter role of vasoactive intestinal peptide. Pharmacol. Toxicol. 72:1993;354-363.
2. Ottesen B., Fahrenkrug J. Vasoactive intestinal polypeptide and other preprovasoactive intestinal polypeptide-derived peptides in the female and male genital tract: localization, biosynthesis, and functional and clinical significance. Am. J. Obstet. Gynecol. 172:1995;1615-1631.
3. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52:2000;269-324.
4. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37:1992;287-303.
5. Kimura C., Ohkubo S., Ogi K., Hosoya M., Itoh Y., Onda H.et al. A novel peptide which stimulates adenylate cyclase: molecular cloning and characterization of the ovine and human cDNAs. Biochem. Biophys. Res. Commun. 166:1990;81-89.
6. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R.et al. International Union of Pharmacology: XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
7. Uddman R., Edvinsson L. Neuropeptides in the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1:1989;230-252.
8. White R.P. Responses of human basilar arteries to vasoactive intestinal polypeptide. Life Sci. 41:1987;1155-1163.
9. Saetrum O.O., Edvinsson L. Effect of parasympathetic and sensory transmitters on human epicardial coronary arteries and veins. Pharmacol. Toxicol. 78:1996;273-279.
10. Gulbenkian S., Saetrum O.O., Ekman R., Costa A.N., Wharton J., Polak J.M.et al. Peptidergic innervation of human epicardial coronary arteries. Circ. Res. 73:1993;579-588.
11. Tsukahara T., Hongo K., Kassell N.F., Ogawa H. The influence of experimental subarachnoid hemorrhage on the relaxation induced by vasoactive intestinal polypeptide in the cerebral arteries of the rabbit. Neurosurgery. 24:1989;731-735.
12. Accili E.A., Buchan A.M., Kwok Y.N., Ledsome J.R., Brown J.C. Presence and actions of vasoactive intestinal peptide in the isolated rabbit heart. Can. J. Physiol. Pharm. 73:1995;134-139.
13. Bruch L., Bychkov R., Kastner A., Bulow T., Ried C., Gollasch M.et al. Pituitary adenylate-cyclase-activating peptides relax human coronary arteries by activating K(ATP) and K(Ca) channels in smooth muscle cells. J. Vasc. Res. 34:1997;11-18.
14. Kastner A., Bruch L., Will-Shahab L., Modersohn D., Baumann G. Pituitary adenylate cyclase activating peptides are endothelium-independent dilators of human and porcine coronary arteries. Agents Actions Suppl. 45:1995;283-289.
15. Dorner G.T., Wolzt M., Eichler H.G., Schmetterer L. Effect of pituitary adenylate cyclase activating polypeptide 1-27 on ocular, cerebral and skin blood flow in humans. Naunyn-Schmiedeberg's Arch. Pharmacol. 358:1998;657-662.
16. Skakkebaek M.L., Georg B., Mikkelsen J.D., Ottesen B., Fahrenkrug J. All prepro-VIP-derived peptides, except PHI/PHV, are expressed in the female rat anterior pituitary and increased by estrogen. Peptides. 16:1995;1287-1294.
17. Palle C., Bredkjaer H.E., Fahrenkrug J., Ottesen B. Vasoactive intestinal polypeptide loses its ability to increase vaginal blood flow after menopause. Am. J. Obstet. Gynecol. 164:1991;556-558.
18. Corr L.A., Poole-Wilson P., Burnstock G. Responses of coronary arteries to neurotransmitters: changes with sexual maturity in the female rabbit. J. Cardiovasc. Pharmacol. 18:1991;144-150.
19. Henning R.J., Sawmiller D.R. Vasoactive intestinal peptide: cardiovascular effects. Cardiovasc. Res. 49:2001;27-37.
20. Wild R.A. Estrogen: effects on the cardiovascular tree. Obstet. Gynecol. 87:1996;27S-35S.
21. Dalsgaard T., Larsen C.R., Mortensen A., Larsen J.J., Ottesen B. New animal model for the study of postmenopausal coronary and cerebral artery function: the Watanabe heritable hyperlipidemic rabbit fed on a diet avoiding phytoestrogens. Climacteric. 5:2002;178-189.
22. Hannibal J., Mikkelsen J.D., Clausen H., Holst J.J., Wulff B.S., Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Pept. 55:1995;133-148.
23. Fahrenkrug J., Schaffalitzky de Muckadell O.B. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J. Lab. Clin. Med. 89:1977;1379-1388.
24. Fahrenkrug J., Schaffalitzky de Muckadell O.B. Distribution of vasoactive intestinal polypeptide (VIP) in the porcine central nervous system. J. Neurochem. 31:1978;1445-1451.
25. Fahrenkrug J., Hannibal J. Pituitary adenylate cyclase activating polypeptide innervation of the rat female reproductive tract and the associated paracervical ganglia: effect of capsaicin. Neuroscience. 73:1996;1049-1060.
26. Emment Y., Collins W.P., Sommerville I.F. Radioimmunoassay of oestrone and oestradiol in human plasma. Acta Endocrinol. (Copenh.). 69:1972;567-582.
27. Mulvany M.J., Nyborg N. An increased calcium sensitivity of mesenteric resistance vessels in young and adult spontaneously hypertensive rats. Br. J. Pharmacol. 71:1980;585-596.
28. Mulvany M.J., Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41:1977;19-26.
29. Hansen V.B., Skajaa K., Aalkjaer C., Oxlund H., Glavind E.B., Petersen O.B.et al. The effect of oophorectomy on mechanical properties of rabbit cerebral and coronary isolated small arteries. Am. J. Obstet. Gynecol. 175:1996;1272-1280.
30. Ottesen B., Larsen J.J., Staun-Olsen P., Gammeltoft S., Fahrenkrug J. Influence of pregnancy and sex steroids on concentration, motor effect and receptor binding of VIP in the rabbit female genital tract. Regul. Pept. 11:1985;83-92.
31. Tseng J.K., Sun B., Tseng L. The effect of progestin on rabbit endometrial aromatase activity. J. Steroid Biochem. 29:1988;9-13.
32. Murugesan K., Vij U., Lal B., Farooq A. Effect of progestins, estradiol, and coenzymes NAD and NADPH on the interconversion of estradiol and estrone in rabbit uterus in vitro. Steroids. 53:1989;695-712.
33. Coldham N.G., James V.H. A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17 beta-hydroxysteroid dehydrogenase activity. Int. J. Cancer. 45:1990;174-178.
34. Fahrenkrug J., Hannibal J., Tams J., Georg B. Immunohistochemical localization of the VIP1 receptor (VPAC1R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J. Cereb. Blood Flow Metab. 20:2000;1205-1214.
35. Kawasaki J., Kobayashi S., Miyagi Y., Nishimura J., Fujishima M., Kanaide H. The mechanisms of the relaxation induced by vasoactive intestinal peptide in the porcine coronary artery. Br. J. Pharmacol. 121:1997;977-985.
36. Edvinsson L., Adamsson M. Neuropeptide Y inhibits relaxation of guinea pig cerebral, coronary, and uterine arteries: blockade by D-myo-inositol-1,2,6-triphosphate. J. Cardiovasc. Pharmacol. 20:1992;466-472.
37. Anzai M., Suzuki Y., Takayasu M., Kajita Y., Mori Y., Seki Y.et al. Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles. Eur. J. Pharmacol. 285:1995;173-179.
38. Tong S., Parfenova H., Shibata M., Zuckerman S., Armstead W.M., Leffler C.W. Pituitary adenylate cyclase-activating polypeptide dilates cerebral arterioles of newborn pigs. Proc. Soc. Exp. Biol. Med. 203:1993;343-347.
39. Jansen-Olesen I., Goadsby P.J., Uddman R., Edvinsson L. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. J. Auton. Nerv. Syst. 49:1994;S97-S103. [Suppl.].
40. Edvinsson L., Fahrenkrug J., Hanko J., McCulloch J., Owman C., Uddman R. Vasoactive intestinal polypeptide: distribution and effects on cerebral blood flow and metabolism. Cervós-Navarro J., Fritschka E. Cerebral microcirculation and metabolism. 1981;147-155 Raven Press, New York.